Brief: Neurosense Regains Compliance With Nasdaq Minimum Bid Price Rule

Neurosense Therapeutics

24/09/2024 14:22

Sept 24 (Reuters) - Neurosense Therapeutics Ltd
 NRSN.O :
    * NEUROSENSE REGAINS COMPLIANCE WITH NASDAQ MINIMUM BID
PRICE RULE

Source text for Eikon:  ID:nPn78NWbha 
Further company coverage:  NRSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))